Neuroradiology: Page 79

Ariz. group follows MUSE to 15-minute MRI scans

By Wayne Forrest

Researchers at the University of Arizona are on a path to creating an MRI protocol that could produce high-resolution brain images in as little as 15 minutes to benefit patients who have an especially difficult time remaining still during scans.

January 8, 2019

Quantib wins FDA clearance for brain MRI AI software

By AuntMinnie.com staff writers

Medical image quantification software developer Quantib has received U.S. Food and Drug Administration (FDA) clearance for its Quantib Neurodegenerative artificial intelligence (AI)-based software.

January 7, 2019

FDA clears therapy product from MRI Interventions

By AuntMinnie.com staff writers

MRI Interventions has received U.S. Food and Drug Administration (FDA) clearance for ClearPoint Pursuit, the company's first internally developed therapeutic product.

January 3, 2019

Is menopause a good time to treat women for Alzheimer's?

By Wayne Forrest

By using women's menopausal status and levels of beta-amyloid plaque as markers for possible progression to Alzheimer's disease, researchers are hoping to determine the best time to begin treatment to slow the onset of the condition, according to a study published online December 12 in PLOS One.

December 20, 2018

AR aids image-guided spinal procedures on live patients

By Abraham Kim

Researchers from Washington, DC, have successfully used augmented reality (AR) technology to perform image-guided spinal procedures on patients with an accuracy matching that of traditional fluoroscopy, according to research presented at the RSNA 2018 meeting in Chicago.

December 19, 2018

MRI provides unique views of youth concussion

By AuntMinnie.com staff writers

By combining structural and functional MRI (fMRI), Canadian and Dutch researchers have identified three unique patterns in the brain to better monitor concussions in young female athletes, according to a study published online December 3 in NeuroImage: Clinical.

December 18, 2018

InSightec gets expanded indication for Exablate Neuro

By AuntMinnie.com staff writers

MR-guided focused ultrasound developer InSightec has received approval from the U.S. Food and Drug Administration for an expanded indication of its Exablate Neuro device to treat patients with tremor-dominant Parkinson's disease.

December 18, 2018

AI could bring ultralow-dose imaging to amyloid PET

By Wayne Forrest

With the help of artificial intelligence (AI), researchers have developed a way to generate diagnostic-quality images from PET/MR scans to detect amyloid deposits with considerably less radiotracer dose. Their findings were published online December 11 in Radiology.

December 17, 2018

FDA to review Blue Earth's Axumin for brain cancer

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has accepted molecular imaging firm Blue Earth Diagnostics' supplemental new drug application for the use of its Axumin (fluciclovine F-18) PET radiopharmaceutical in brain cancer detection.

December 10, 2018

Advanced MRI better option for brain tumor recurrence

By Wayne Forrest

Is PET or MRI better for detecting tumor recurrence in patients with brain metastases who received radiation therapy? While PET and conventional MRI performed about the same, MRI gets the edge if advanced scanning sequences are used, according to a Korean study in the December issue of the American Journal of Roentgenology.

December 10, 2018

PET shows efficacy of tuberculosis meningitis drug

By AuntMinnie.com staff writers

With the help of PET scans, researchers at Johns Hopkins Medicine are gathering information on why the drug rifampin is not very effective in treating tuberculosis meningitis of the brain. They reported their results in a study published online December 5 in Science Translational Medicine.

December 6, 2018

New PET tracer could better connect tau to Alzheimer's

By Wayne Forrest

Clinicians may soon have a new PET tracer to improve the detection of tau protein tangles in the brain, advancing the diagnosis of Alzheimer's disease and subsequently leading to more effective treatments for dementia, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

Previous Page

Page 79 of 238

Next Page